Novo Nordisk
NVO
580 hedge funds and large institutions have $9.18B invested in Novo Nordisk in 2019 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 171 increasing their positions, 204 reducing their positions, and 41 closing their positions.
152% more call options, than puts
Call options by funds: $58.1M | Put options by funds: $23.1M
88% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 41
15% more capital invested
Capital invested by funds: $7.99B → $9.18B (+$1.19B)
5% more funds holding
Funds holding: 550 → 580 (+30)
0.2% more ownership
Funds ownership: 18.15% → 18.35% (+0.2%)
16% less repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 204
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$46.1M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$41.4M |
| 3 |
Jennison Associates
New York
|
+$31.9M |
| 4 |
Renaissance Technologies
New York
|
+$29.5M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$26.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Alta Capital Management
Salt Lake City,
Utah
|
-$41.5M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$26.6M |
| 3 |
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
|
-$26M |
| 4 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$23.6M |
| 5 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$20.1M |
NVO Hedge Fund Activity: Q1 2019 in Review
580 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2019, worth a combined $9.18B — up 15% from $7.99B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new NVO positions and 41 closed out — a net gain of 36 holders — while 171 added to existing stakes and 204 trimmed.
The largest buyer was Amundi Asset Management US, opening a new position worth an estimated $46.1M. The largest seller was Alta Capital Management, cutting an estimated $41.5M.
- 580 institutional investors held Novo Nordisk (NVO) as of Q1 2019, up from 550 in Q4 2018.
- Funds reported $9.18B of Novo Nordisk stock for Q1 2019, up 15% quarter-over-quarter.
- 77 funds opened new Novo Nordisk positions in Q1 2019 and 41 closed out, a net change of +36 holders.
- The largest Novo Nordisk buyer in Q1 2019 was Amundi Asset Management US, an estimated $46.1M added.
- The largest Novo Nordisk seller in Q1 2019 was Alta Capital Management, an estimated $41.5M sold.
Based on aggregated 13F filings for Q1 2019.